期刊文献+

艾司西酞普兰合并无抽搐电休克治疗自杀未遂抑郁症疗效观察 被引量:3

Efficiency of modified electroconvulsive therapy combined with escitalopram for depression with attempted suicide
下载PDF
导出
摘要 目的探讨艾司西酞普兰合并无抽搐电休克(MECT)治疗自杀未遂抑郁症患者的疗效。方法将68例自杀未遂的抑郁症患者随机分为研究组35例和对照组33例,研究组予以艾司西酞普兰合并MECT治疗,对照组单用艾司西酞普兰治疗,共观察28 d,分别于治疗前及治疗后第3、7、14、21、28天予以汉密尔顿抑郁量表17项(HAMD-17)和贝克自杀意念量表(BSI)评定。结果研究组HAMD、BSI评分在治疗后第3天起即较治疗前显著下降(P<0.05),而对照组则在治疗后第7天起较治疗前显著下降(P<0.05)。研究组在治疗后各个评分点HAMD、BSI评分均低于对照组(P均<0.05)。结论艾司西酞普兰合并MECT治疗自杀未遂抑郁症患者疗效确切,起效快,优于单用艾司西酞普兰治疗。 Objective To explore the efficiency of modified electroconvulsive therapy (MECT) combined with escitalopram in the treatment of depression with attempted suicide. Methods 68 depressed patients with attempted suicide were randomized into study group (35 cases ) treated with MECT combined with eseitalopram and control group (33 cases ) treated with escitalopram monotherapy for 28 days. All patients were assessed with 17-item Hamilton Depressive Scale ( HAMD-17 ) and Beck Scale for Suicide Ideation (BSI) at the baseline and at the 3rd, 7th, 14th, 21th, 28th day of the treatment. Results Compared with baseline, scores of HAMD-17 and BSI decreased significantly from the 3rd day in study group (P 〈0.05) , while from the 7th day in control group ( P 〈 0.05 ). Scores of HAMD-17 and BSI in study group were significantly lower than those in control group at each post-treatment interview ( P 〈 0.05 ). Conclusion Compared with escitalopram monotherapy, MECT combined with escitalopram has better efficiency and takes effect more quickly in the treatment of depression with attempted suicide.
出处 《精神医学杂志》 2014年第4期266-267,共2页 Journal of Psychiatry
关键词 抑郁症 自杀未遂 艾司西酞普兰 无抽搐电休克 Depression Attempted suicide Escitalopram MECT
  • 相关文献

参考文献9

二级参考文献44

  • 1陈国强,沈其杰,郑洪波,高欢,赵振环,冯容妹,黄远光.国产氯丙咪嗪针剂治疗抑郁症临床观察[J].中国神经精神疾病杂志,1993,19(1):32-35. 被引量:2
  • 2潘能荣,杨小男,张承安,梅其一.电休克治疗对抑郁症的疗效研究[J].临床精神医学杂志,2005,15(2):75-77. 被引量:76
  • 3刘焕军,刘东红,杜红兴.无抽搐电休克治疗癔症16例临床分析[J].山东精神医学,2005,18(3):166-166. 被引量:9
  • 4BRKEU WJ. Escitalopram[J]. Expert Opin Investig Drugs, 2002, 11(10): 1477-1486.
  • 5BIELSKI RJ, BOSE A, CHANG CC. A double-blind comparison of escitalopram and paroxetine in the long-term treatment of generalized anxiety disorder[J]. Ann Clin Psychiatry, 2005, 17 (2) : 65-69.
  • 6MURDOCH D, KEAM SJ. Eseitalopram: a review of its use in the management of major depressive disorder[J]. Drugs, 2005, 65(16) : 2379-2404.
  • 7GORMAN JM, KOROTZER A, SU G. Efficacy comparison of escitalopram and citalopram in the treatment of major depressive disorder: pooled analysis of placebo-controlled trials [J]. CNS Spectr,2002, 7(4 Suppl 1): 40-44.
  • 8Coryell W, Scheftner W, Keller M, et al. The enduring psycho - social consequences of mania and depression [ J ]. Am J Psychiatry, 1993,150:720 - 727.
  • 9Montgomery SA. Clinically relevant effect sizes in depression [ J ]. Eur Neuropsycharm, 1994,4 : 283 - 284.
  • 10Bostwick JM, Pankratz VS. Affective disorders and suicide risk: A reexamination [ J ]. Am J Psychiatry, 2000,157 : 1925 - 1932.

共引文献48

同被引文献20

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部